324 related articles for article (PubMed ID: 31040292)
1. FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
Li SY; Chu PH; Huang PH; Hsieh TH; Susztak K; Tarng DC
Sci Rep; 2019 Apr; 9(1):6693. PubMed ID: 31040292
[TBL] [Abstract][Full Text] [Related]
2. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
3. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.
Blattner SM; Hodgin JB; Nishio M; Wylie SA; Saha J; Soofi AA; Vining C; Randolph A; Herbach N; Wanke R; Atkins KB; Gyung Kang H; Henger A; Brakebusch C; Holzman LB; Kretzler M
Kidney Int; 2013 Nov; 84(5):920-30. PubMed ID: 23677246
[TBL] [Abstract][Full Text] [Related]
4. Kindlin-2 Association with Rho GDP-Dissociation Inhibitor
Sun Y; Guo C; Ma P; Lai Y; Yang F; Cai J; Cheng Z; Zhang K; Liu Z; Tian Y; Sheng Y; Tian R; Deng Y; Xiao G; Wu C
J Am Soc Nephrol; 2017 Dec; 28(12):3545-3562. PubMed ID: 28775002
[TBL] [Abstract][Full Text] [Related]
5. Rac1 activation in podocytes induces rapid foot process effacement and proteinuria.
Yu H; Suleiman H; Kim AH; Miner JH; Dani A; Shaw AS; Akilesh S
Mol Cell Biol; 2013 Dec; 33(23):4755-64. PubMed ID: 24061480
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of podocyte FAK protects against proteinuria and foot process effacement.
Ma H; Togawa A; Soda K; Zhang J; Lee S; Ma M; Yu Z; Ardito T; Czyzyk J; Diggs L; Joly D; Hatakeyama S; Kawahara E; Holzman L; Guan JL; Ishibe S
J Am Soc Nephrol; 2010 Jul; 21(7):1145-56. PubMed ID: 20522532
[TBL] [Abstract][Full Text] [Related]
7. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
8. Dosage-dependent role of Rac1 in podocyte injury.
Wan X; Lee MS; Zhou W
Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
[TBL] [Abstract][Full Text] [Related]
9. Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice.
Lv Z; Hu M; Fan M; Li X; Lin J; Zhen J; Wang Z; Jin H; Wang R
Cell Death Dis; 2018 Mar; 9(3):342. PubMed ID: 29497040
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
Scott RP; Hawley SP; Ruston J; Du J; Brakebusch C; Jones N; Pawson T
J Am Soc Nephrol; 2012 Jul; 23(7):1149-54. PubMed ID: 22518006
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.
Ishizaka M; Gohda T; Takagi M; Omote K; Sonoda Y; Oliva Trejo JA; Asao R; Hidaka T; Asanuma K; Horikoshi S; Tomino Y
Biochem Biophys Res Commun; 2015 Nov; 467(3):549-55. PubMed ID: 26435502
[TBL] [Abstract][Full Text] [Related]
12. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
[TBL] [Abstract][Full Text] [Related]
13. ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics.
Lin JS; Jeon JS; Fan Q; Wong HN; Palmer MB; Holzman LB
PLoS One; 2017; 12(9):e0184575. PubMed ID: 28880939
[TBL] [Abstract][Full Text] [Related]
14. Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling.
Duan Y; Qiu Y; Huang X; Dai C; Yang J; He W
J Mol Med (Berl); 2020 Feb; 98(2):291-307. PubMed ID: 31927599
[TBL] [Abstract][Full Text] [Related]
15. Role of γ-adducin in actin cytoskeleton rearrangements in podocyte pathophysiology.
Gao W; Liu Y; Fan L; Zheng B; Jefferson JR; Wang S; Zhang H; Fang X; Nguyen BV; Zhu T; Roman RJ; Fan F
Am J Physiol Renal Physiol; 2021 Jan; 320(1):F97-F113. PubMed ID: 33308016
[TBL] [Abstract][Full Text] [Related]
16. Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.
Verma R; Venkatareddy M; Kalinowski A; Patel SR; Salant DJ; Garg P
Mol Cell Biol; 2016 Feb; 36(4):596-614. PubMed ID: 26644409
[TBL] [Abstract][Full Text] [Related]
17. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
[TBL] [Abstract][Full Text] [Related]
18. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
[TBL] [Abstract][Full Text] [Related]
19. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
20. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
